Lidamidine hydrochloride. American College of Gastroenterology Committee on FDA-Related Matters.
D000818:Animals; D000930:Antidiarrheals / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005260:Female; D005769:Gastrointestinal Motility / Q000187:drug effects; D006801:Humans; D007408:Intestinal Absorption; D008297:Male; D010671:Phenylurea Compounds / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use
D000930:Antidiarrheals; D010671:Phenylurea Compounds; C020918:lidamidine